Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

FDA Approval of Biopharma's Pain Drug Expected This Year

The reasons a green light is anticipated and how it relates to the closing of Avenue Therapeutics' pending acquisition are discussed in an H.C. Wainwright & Co. report. In a Feb. 13 research note, H.C. Wainwright & Co. analyst Ed Arce reported that the U.S. ...
Streetwise Reports | February 20, 2020 |

Technical Analyst:Mega-Profitable Strategy for Next Heavy US Stock Market Down Leg Believed Imminent

Technical analyst Clive Maund discusses what he sees ahead for the markets. We are going to look at an array of important factors pointing to another severe drop in the broad U.S. stock market imminently, both factors external to it and indications on the charts fo...
Streetwise Reports | April 2, 2020 |

The Second Massive Downwave Is Almost Upon Us

Technical analyst Clive Maund charts the markets and discusses what he believes is ahead for stocks, the dollar and commodities. Notwithstanding the Fed's seemingly limitless ability to create money to throw at the stock market, which has caused it to rally in rece...
Streetwise Reports | May 5, 2020 |

Biopharma Shows 'Good Start to 2020 News Flow'

The two developments that already took place this year are addressed in an H.C. Wainwright & Co. report. In a Jan. 16 research note, H.C. Wainwright & Co. analyst Joseph Pantginis reported that Ligand Pharmaceuticals Inc. (LGND:NASDAQ) kicked off the year with news ...
Streetwise Reports | January 22, 2020 |

Immunotherapy Firm Releases Data Showing Treatment Potential Against Sepsis

Recently presented results from Enlivex Therapeutics' Phase 1b study in sepsis and their implications are reviewed in an H.C. Wainwright & Co. report. In a June 1 research note, H.C. Wainwright & Co. analyst Ram Selvaraju reported that Enlivex Therapeutics Ltd.'s ...
Streetwise Reports | June 4, 2020 |

June 23rd 2020, Crypto Chartbook: Success is when preparation meets opportunity

Success is when preparation meets opportunity Why screen exposure and overall experience is so needed in the field of trading is related to the fact that the market has a high degree of variability. It takes years to have seen at least a good part of the various things th...
Korbinian Koller | June 23, 2020 |

Gold Market Update: Metal Up, Dollar Down

Technical expert Clive Maund charts the reasons the precious metals have entered a bull market. Gold is now a major bull market, as evidenced by its strong breakout from a giant 6-year long base pattern in August. The larger trend is up. We had thought that it might r...
Streetwise Reports | January 2, 2020 |

Stock Market & Flu Breakdown Metrics – Where’s The Bottom?

The end of February was brutal for traders that were not prepared for the breakdown in the US stock markets. The breakdown in price actually started on February 20th and 21st. Most traders didn’t pay attention to these minor downside price rotations in the Te...
Chris Vermeulen | March 3, 2020 |

Technical Analyst: Silver's Massive Undervaluation Relative to Gold Makes It Irresistible

Technical analyst Clive Maund explains why he's bullish on silver. The way you see silver now depends on whether you see a glass that is half empty or half full. If you are a pessimist by nature you will be grumbling about its underperformance relative to go...
Streetwise Reports | May 12, 2020 |

Why Silver Stocks Should Be on Investors' Radar

Technical analyst Clive Maund explains why he believes investors should be looking at silver right now. We are now entering the final part of the endgame of the latest fiat experiment and the actions of the Fed and other central banks virtually guarantee that most ...
Streetwise Reports | May 22, 2020 |
1 2 3 4 5 6 7 8 9 10 ...